1-7 of 7
Juliana Biondo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Fixed-duration subcutaneous (SC) mosunetuzumab, with maintenance therapy, in patients (pts) with previously untreated high-tumor burden follicular lymphoma (HTB FL): Longer follow-up and exploratory circulating tumor (ct)DNA analysis of the Phase II MorningSun study

Free
John M. Burke, Jeff Sharman, Bertrand Anz, Richard Zuniga, Aung Tun, David Wright, Prachi Jani, Juliana Biondo, Mei Wu, Yong Mun, Vivek S. Chopra, Rona Farighi, Jose Villasboas Bisneto, Elizabeth Budde, Ian Flinn
Journal: Blood
Blood (2025) 146 (Supplement 1): 228.
https://doi.org/10.1182/blood-2025-228
Published: 2025
Journal Articles

Fixed-duration subcutaneous mosunetuzumab demonstrates sustained clinically meaningful outcomes in patients with previously untreated, low-tumor burden follicular lymphoma

Free
Jose Villasboas Bisneto, John M. Burke, Aung Tun, Steve Liu, Jeff Sharman, Juliana Biondo, Prachi Jani, Mei Wu, Yong Mun, Vivek S. Chopra, Rona Farighi, Javier Munoz, Furhan Yunus, Ian Flinn, Elizabeth Budde
Journal: Blood
Blood (2025) 146 (Supplement 1): 1807.
https://doi.org/10.1182/blood-2025-1807
Published: 2025
Journal Articles

Fixed treatment duration subcutaneous mosunetuzumab monotherapy in elderly/unfit patients with previously untreated diffuse large B-cell lymphoma: Interim results from the Phase II MorningSun study

Free
Jeff Sharman, Aung Tun, Jose Villasboas Bisneto, Ayed Ayed, Prachi Jani, Juliana Biondo, Mei Wu, Farah Hossain, Yong Mun, Vivek S. Chopra, Rona Farighi, Jamal Misleh, Shachar Peles, Ian Flinn, John M. Burke
Journal: Blood
Blood (2025) 146 (Supplement 1): 62.
https://doi.org/10.1182/blood-2025-62
Published: 2025
Journal Articles

Understanding Patient Preferences for Chronic Lymphocytic Leukemia Treatments

Free
Arliene Ravelo, Kelley Myers, Robyn Brumble, Cooper Bussberg, Brian Koffman, Beenish S. Manzoor, Juliana Biondo, Carol Mansfield
Journal: Blood
Blood (2022) 140 (Supplement 1): 10803–10805.
https://doi.org/10.1182/blood-2022-159648
Published: 2022
Journal Articles

Real-World Assessment of Second Primary Malignancies in a Treated and Untreated Chronic Lymphocytic Leukemia Population in the United States

Free
Sikander Ailawadhi, Arliene Ravelo, Carmen Ng, Bonny Shah, Rongrong Wang, Katherine Eakle, Juliana Biondo
Journal: Blood
Blood (2022) 140 (Supplement 1): 8040–8041.
https://doi.org/10.1182/blood-2022-158139
Published: 2022
Journal Articles

Outcomes of Ibrutinib Therapy Given after Prior Venetoclax Therapy in Ibrutinib-Naïve Patients with Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL)

Free
Jennifer R. Brown, MD PhD, Matthew S Davids, Julie Chang, Shuo Ma, MD PhD, Juliana Biondo, Mehrdad Mobasher, MD MPH, Yong Mun, PhD, Anthony R Mato, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5556.
https://doi.org/10.1182/blood-2018-99-116942
Published: 2018
Journal Articles

Patterns of Ibrutinib Use, Discontinuation, and Hospitalization Among Patients with Chronic Lymphocytic Leukemia (CLL) in a US Healthcare Claims Database

Free
Tu My To, PhD MPH, Wei-Shi Yeh, PhD MS, Juliana Biondo, Anthony S Masaquel, PhD MPH
Journal: Blood
Blood (2018) 132 (Supplement 1): 5909.
https://doi.org/10.1182/blood-2018-99-112679
Published: 2018